Clarification on the news article by China Times

Date of occurrence: July 12, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A Name of mass media: China Times Page B4; Economic Daily News Page C6 Content reported: China times reported that “OBI stepped the foot into the anti-cancer drug by […]

This article is password protected.

To view the content, please enter your password in the field below